The library / Topic
Research
Research is the largest topic and the one with the thinnest evidence. Most compounds here are sold online as laboratory products and have been studied in cells, rodents or a few small human reports, if at all. Each article separates those layers, names the species and the stage of every study, and explains why a dosage chart built on rat data is not a human dose.
The overview of what is known about research peptides is the best entry point. MOTS-c sorted by evidence level shows the method applied to one molecule, and the IGF-1 LR3 evidence review compares an unapproved analogue with the one approved IGF-1 label. For handling, see stability, storage and the cold chain.
Research Peptides and the State of the Evidence
Online forums are full of names and nicknames. What do we actually know about the compounds most often discussed, and why is the honest answer so often "not enough"?
ReadWhy Peptides Are Fragile and How Storage and the Cold Chain Help
Peptides break down in surprising ways. Understanding why explains cold-chain logistics, expiry dates and why where a product has been matters as much as what is inside.
ReadMachines That Invent Peptides and the New Era of AI Molecular Design
Algorithms can now predict how chains fold and propose sequences no human has tried. What that means, and where hype ends and results begin.
ReadACE 031 Peptide and How It Works in Muscle Research
ACE-031 is a soluble activin receptor fused to an antibody fragment whose Duchenne trial was stopped in 2011 after nosebleeds and telangiectasias.
ReadEpitalon Peptide Dosage Guide to How Published Schedules Were Built
Published epitalon doses span cell cultures, rodents and small Russian studies with different units and routes. None established a human dose, and the 2026 vote did not change that.
ReadFOX04 Peptide Side Effects and Senolytic Research Overview
FOXO4-DRI is a designed senolytic peptide studied in mice since 2017, with no human trials and therefore no established dose or side effect profile.
ReadGHK Cu Peptide Injection Dosage and Protocol Explained
No clinical trial has tested injected GHK-Cu in people, so cosmetic, cell and animal figures cannot be turned into a human dose, site or schedule.
ReadKVP Peptide Explained and What KPV Research Shows
KPV is a tripeptide from alpha MSH that enters cells through the PepT1 transporter and reduces inflammation in animal colitis models, with no human trials published.
ReadLL 37 Peptide Benefits Dosage and Research Evidence
LL-37 is the human cathelicidin, studied for antimicrobial and wound repair effects, with two topical leg ulcer trials and no approved systemic use.
Read